Bernard Giusiano

Inserm

Papers

1

Total Citations

18

H-Index

1

About

Bernard Giusiano is a leading clinical researcher in the surgical treatment of drug-resistant epilepsy, with a particular focus on neuromodulation of deep brain structures. His major contribution lies in pioneering deep brain stimulation (DBS) of the medial pulvinar nucleus (PuM) of the thalamus as a novel therapeutic target for patients with focal epilepsy who have failed both medication and vagal nerve stimulation. As the principal investigator of the landmark PULSE study, Giusiano’s work has demonstrated that PuM-DBS can significantly reduce seizure frequency while also addressing common comorbidities, offering new hope for the most refractory patient populations. His 2024 interim 12-month results from this open-label prospective trial, which has already garnered 18 citations, represent a critical step forward in expanding the neuromodulation toolkit beyond traditional targets. Giusiano’s research is reshaping the landscape of epilepsy surgery, providing a compelling alternative for patients with limited options and establishing a new paradigm for thalamic stimulation in focal epilepsy.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Medial pulvinar stimulation for focal drug-resistant epilepsy: interim 12-month results of the PULSE study
18 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Inserm

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago